Burcin C. Demirel
Istanbul, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Early host adaptation defined by nutritional and inflammatory dynamics predicts disease progression in solid tumours.
Journal: American journal of cancer research
Published: February 16, 2026
Role of Prognostic Nutritional Index and C-Reactive Protein/Albumin Ratio in Prognosis of Locally Advanced Nasopharyngeal Carcinoma.
Journal: Medicina (Kaunas, Lithuania)
Published: December 30, 2025
Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study.
Journal: BMC cancer
Published: August 03, 2024
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.
Journal: Clinical breast cancer
Published: June 29, 2024
Pretreatment PLR Is Preferable to NLR and LMR as a Predictor in Locally Advanced and Metastatic Bladder Cancer.
Journal: Cancer diagnosis & prognosis
Published: August 12, 2023
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Journal: Future oncology (London, England)
Published: May 03, 2023
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
Journal: BMC cancer
Published: February 28, 2023
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
Journal: BMC cancer
Published: September 15, 2022
The Effect of Continuing Chemotherapy after Chemoradiotherapy during the Time to Surgery on Tumor Response and Survival for Local Advanced Rectal Cancer.
Journal: Journal of oncology
Published: April 29, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026